Selection of Non-vitamin K Antagonist Oral Anticoagulant for Stroke Prevention in Atrial Fibrillation Based on Patient Profile: Perspectives from Vietnamese Experts. Part 1

Selection of Non-vitamin K Antagonist Oral Anticoagulant for Stroke Prevention in Atrial Fibrillation Based on Patient Profile: Perspectives from Vietnamese Experts. Part 1 AF, the most common arrhythmia, affects approximately 60 million people worldwide and contributes to over 8 million disability-adjusted life years.1 Based on published data from Asia, the prevalence of AF is in the range 0.49 –1.9% across different regions.2 Due to an ageing population, the incidence and p...
Source: Radcliffe Cardiology - Category: Cardiology Authors: Source Type: research